No Data
No Data
Growth 50 rebounded, with buying in cover ETC = Emerging Markets, September 9.
The TSE Growth Market 250 Index rebounded. Following the rise in US stocks, the Main Board experienced a solid weekend market. Sanbio <4592.T>, MTG <7806.T>, and Cover <5253.T> saw increases, while BASE <4477.T> and Renascience <4889.T> were sold off. The finance announcement from Astroscale <186A.T> slightly decreased. In the Standard market, the Earnings Reports for Sumitomo Mitsui Trust SBI Silver <7163.T> were sold off. Provided by Wealth Advancer.
Growth 250 fell back, and HENGGE and others declined = Emerging Markets, 8th.
The Tokyo Stock Exchange Growth Market 250 Index fell back. Although leading stocks showed mixed performance, HENGGE <4475.T>, Kauris <153A.T>, and Globing <277A.T> declined, pushing the index down. BASE <4477.T> and Timee <215A.T> also weakened. On the other hand, Renascience <4889.T> and Toyoko <341A.T> rose. Provided by Wealth Advisor Inc.
SBI Reos, Fruta Fruta and others.
<165A> SBI Lear increased Dividends, last period's Dividends per share was 3.80 yen, up from 3.40 yen. <2438> Asukanet has completed the acquisition of its own shares. <2586> Frutta Frutta raises its forecast, last period's operating profit outlook is 0.229 billion yen, up from 0.13 billion yen. <286A> Yukaria has formed a capital and business alliance with Hippocratic AI, Inc. (USA). <341A> Toyoko has revised its forecast, last period's operating profit outlook is 0.301 billion yen, up from 0.184 billion yen. <4475> HENGGE has revised its forecast, this period's operating profit.
Renascience is showing a strong presence, and the number of registered patients has reached the target number of cases for the development of Medical Devices that support maintenance Hemodialysis.
Renacience <4889.T> is showing a pre-market trend. After the market closed on the 9th, it was announced that the number of registered patients for the program Medical Devices utilizing Artificial Intelligence (AI) to support maintenance Hemodialysis has reached the target case number of 150, which was considered a positive development. This project has been adopted by the Japan Agency for Medical Research and Development for the 5th year of the Reiwa era "Medical Devices Development Promotion Research Project" (research representative institution is Tohoku University), and the developed program Medical Devices will provide optimal dialysis conditions (dehydration amount) for patients undergoing maintenance Hemodialysis.
April 10 [Today's Investment Strategy]
[Fisco Selected Stock] [Material Stock] Furuno Electric <6814> 1992 yen (4/9) Engaged in fish finders and other Electronic Equipment for ships. Announced financial results for the period ending February 2025. The operating profit was 13.1 billion yen (double compared to the previous period). The previous Financial Estimates, raised on January 14 from 11 billion yen to 12 billion yen (an increase of 84.0%) were exceeded. Achieved record high revenue and profit for two consecutive years. The operating profit for the period ending February 2026 is expected to be 11.5 billion yen (a decrease of 12.8% compared to the previous period). At the same time,
Key points of attention in PTS on the 9th = ABC Mart, Progrit, iCube ETC.
▽ ABC Mart <2670.T>, the consolidated results for the fiscal year ending February 2025 are expected to fluctuate, while an increase in revenue and profit is forecasted for the fiscal year ending February 2026. ▽ Progrit <9560.T>, the standalone results for the second quarter cumulative period (September 2024 - February 2025) for the fiscal year ending August 2025 are expected to see double-digit increases in revenue and profit. ▽ Grand <9720.T>, the standalone results for the first quarter (December 2024 - February 2025) for the fiscal year ending November 2025 are expected to see double-digit increases in revenue and profit. ▽ iCube <4495.T>, the consolidated profit forecast for the fiscal year ending June 2025 has been revised upward. ▽ Treasure Factory <3093>